About Dynein regulatory complex subunit 4
Dynein regulatory complex subunit 4 (DRC4) is a protein
from Homo sapiens identified by UniProt accession
O95995, 478 residues long.
MolForge cross-references it against 0 known binders and
93 disease associations.
Target properties
| Protein name | Dynein regulatory complex subunit 4 |
| UniProt accession | O95995 |
| Gene | DRC4 |
| Organism | Homo sapiens |
| Length | 478 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (93)
Diseases linked to this target (Open Targets).
- primary ciliary dyskinesia · score 0.69
- hair colour measurement · score 0.50
- skin pigmentation · score 0.47
- hair color · score 0.41
- cancer · score 0.33
- skin pigmentation measurement · score 0.33
- sunburn · score 0.25
- suntan · score 0.24
- neurodegenerative disease · score 0.23
- mathematical ability · score 0.21
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O95995-F1 | alphafold | PREDICTED | 84.45 | — |
Amino-acid sequence (478 residues)
MAPKKKGKKG KAKGTPIVDG LAPEDMSKEQ VEEHVSRIRE ELDREREERN YFQLERDKIH TFWEITRRQL EEKKAELRNK DREMEEAEER HQVEIKVYKQ KVKHLLYEHQ NNLTEMKAEG TVVMKLAQKE HRIQESVLRK DMRALKVELK EQELASEVVV KNLRLKHTEE ITRMRNDFER QVREIEAKYD KKMKMLRDEL DLRRKTELHE VEERKNGQIH TLMQRHEEAF TDIKNYYNDI TLNNLALINS LKEQMEDMRK KEDHLEREMA EVSGQNKRLA DPLQKAREEM SEMQKQLANY ERDKQILLCT KARLKVREKE LKDLQWEHEV LEQRFTKVQQ ERDELYRKFT AAIQEVQQKT GFKNLVLERK LQALSAAVEK KEVQFNEVLA ASNLDPAALT LVSRKLEDVL ESKNSTIKDL QYELAQVCKA HNDLLRTYEA KLLAFGIPLD NVGFKPLETA VIGQTLGQGP AGLVGTPT
Explore Dynein regulatory complex subunit 4 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets